Literature DB >> 19660841

[Cardiovascular risk factors: a follow up study in a non-diabetic population].

María Vernet Vernet1, María José Sender Palacios, Esther Jovell Fernández, Encarnació Tor Figueras, Ramón Casals Riera, Pere Larrosa Sàez.   

Abstract

OBJECTIVES: To evaluate the cardiovascular risk factors (CVRF), their relationship with insulin resistance (IR) and pancreatic beta-cell (PBC) function in a known non-diabetic population, and to follow its progress over a period of 5 years.
DESIGN: Nested case-control study developed in two phases: the identification and characterisation of the cohort to study and the follow up.
SETTING: Urban Primary Care Centre. PARTICIPANTS: A non-diabetic population sample from 40 to 70 years. MAIN MEASUREMENTS: History of CVRF, physical examination (body mass index, abdominal girth, blood pressure), laboratory tests (fasting glucose, lipid profile and fasting insulin) and calculation of IR and PBC using the Homeostasis Model Assessment mathematical program.
RESULTS: Identification phase: 326 subjects. CVRF 32.5% dyslipaemia, 28.8% smoking, 28.2% obesity and 24.8% increased blood pressure. Number of CVRF: 37.7% had one, 21.5% two, 10.1% three and 2.1% four. Relationship between number of CVRF and IR. More IR in hypertensive, obese and dyslipaemic subjects. Follow up phase (5 years): 121 subjects. Significant proportion of dyslipaemia and impaired fasting glucose (IFG).
CONCLUSIONS: The most common CVRF were dyslipaemia, smoking, obesity and raised blood pressure, with more IR in patients with high blood pressure, dyslipaemia and obesity and a higher number of CVRF in comparison with the rest of the population. At five years of follow up, an increase was only observed in the number of dyslipaemia and IFG and no reduction was achieved in the percentage of active smokers. Copyright (c) 2009 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19660841      PMCID: PMC7022061          DOI: 10.1016/j.aprim.2009.03.016

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  26 in total

1.  [Prevalence of cardiovascular risk factors in the Balearic Islands (CORSAIB Study)].

Authors:  Fernando Rigo Carratalá; Guillem Frontera Juan; Joan Llobera Cànaves; Tomás Rodríguez Ruiz; Isabel Borrás Bosch; Emilia Fuentespina Vidal
Journal:  Rev Esp Cardiol       Date:  2005-12       Impact factor: 4.753

2.  A prospective analysis of the HOMA model. The Mexico City Diabetes Study.

Authors:  S M Haffner; E Kennedy; C Gonzalez; M P Stern; H Miettinen
Journal:  Diabetes Care       Date:  1996-10       Impact factor: 19.112

3.  Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study.

Authors:  Krisela Steyn; Karen Sliwa; Steven Hawken; Patrick Commerford; Churchill Onen; Albertino Damasceno; Stephanie Ounpuu; Salim Yusuf
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

4.  Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women.

Authors:  M J Vanhala; E A Kumpusalo; T K Pitkäjärvi; I L Notkola; J K Takala
Journal:  J Hypertens       Date:  1997-05       Impact factor: 4.844

5.  [High cardiovascular risk due to inadequate control of risk factors in Spanish hypertensive patients seen in the Spanish primary care].

Authors:  B Alvarez Alvarez; M Luque Otero; N Martell Claros; M D López-Eady
Journal:  Rev Clin Esp       Date:  2006-11       Impact factor: 1.556

6.  [Prevalence of obesity in Spain].

Authors:  J L Gutiérrez-Fisac; E Regidor; C Rodríguez
Journal:  Med Clin (Barc)       Date:  1994-01-15       Impact factor: 1.725

Review 7.  How to measure insulin sensitivity.

Authors:  E Ferrannini; A Mari
Journal:  J Hypertens       Date:  1998-07       Impact factor: 4.844

8.  [Study of vascular risk in Navarre: objectives and design. Prevalence of metabolic syndrome and of vascular risk factors].

Authors:  J J Viñes; J Díez; M J Guembe; P González; C Amézqueta; J Barba; I Sobejano; E Martínez-Vila; A M Grijalba; M Serrano; C Moreno; E Los-Arcos; D Guerrero
Journal:  An Sist Sanit Navar       Date:  2007 Jan-Apr       Impact factor: 0.829

9.  [Treatment and control of cardiovascular risk in primary care in Spain. The PREVENCAT study].

Authors:  Antonio Coca; Antonio Dalfó; Enric Esmatjes; José Luis Llisterri; Jordi Ordóñez; Ramón Gomis; José Ramón González-Juanatey; Armando Martín-Zurro
Journal:  Med Clin (Barc)       Date:  2006-02-18       Impact factor: 1.725

10.  [Degree of understanding, treatment and control of hypertension, hypercholesterolemia and diabetes mellitus in the general adult population].

Authors:  M Pineda Cuenca; J Custardoy Olavarrieta; J M Ortín Arróniz; J G Cano Montoro; M T Andreu Ruiz; C Grau
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.